Our technique for intraventricular pressure monitoring is simple and can be done by the physician at the bedside. In only one case did monitoring fail (failure rate 2%). There was one case of secondary sepsis and no long term sequelae. There were no intracerebral haemorrhages. The only major difference in our management from that of the authors was that we used continuous infusions of morphine and pancuronium rather than bolus doses.
Twenty seven of our patients had a good or moderate neurological outcome and four were severely handicapped using the Seshia scale of assessment.4 Seventeen patients died. These results are very similar to those of the authors. The average cerebral perfusion pressure of our normal survivors, however, was 36-5 mm Hg, and nine of these 18 normal survivors had minimum cerebral perfusion pressure of less than 40 mm Hg. The duration of the minimum cerebral perfusion pressure could not be assessed as only hourly observations were charted by the nursing staff (in addition to the acute changes in cerebral perfusion pressure). Three of the 17 who died had a minimum cerebral perfusion pressure of greater than 45 mm Hg, but the average minimum of those who died was 20-7 mm Hg.
The difference was significant (p less than 0-05 by paired t test). In contrast with the authors' experience a child with Reye's syndrome who had maximum intracranial pressure of 65 mm Hg survived to be normal. Eight of our survivors had a Glasgow coma scale of less than 5 (not attributable to drugs) before monitoring of intracranial pressure.
There are several areas of intracranial pressure monitoring which need further clarification. The question of what is an adequate cerebral perfusion pressure has yet to be resolved. Factors such as regional blood flow variation, duration of minimum cerebral perfusion pressure, and the underlying disease process may be of great importance. We feel that taking a cerebral perfusion pressure of 40 mm Hg as a cut off point without regard to the underlying illness and the duration of that pressure is at present wrong, and that more prospective research is needed in this area. Further, with our experience we would suggest that a Glasgow coma scale at less than 5 is not necessarily an indicator of a poor outcome. Therefore, neither of these parameters should necessarily be used to decide on the initiation or continuation of a treatment.
Finally, it is not clear how many of the patients of Tasker et al were transferred from other hospitals before the institution of neurointensive care. Over the past six months we have provided an intensive care transport service for critically ill children. During that period we have been asked to transport four children in whom the intracranial pressure was definitely raised or impaired cerebral perfusion pressure was suspected. In all cases the children were assessed by one of the authors and measures taken to reduce intracranial pressure and to stabilise mean arterial pressure before transfer from the referring hospital. We feel that in this way fluctuations in cerebral perfusion pressure may be minimised. Identifying illnesses in which cerebral perfusion pressure is significantly reduced and developing scoring systems allowing timely intervention may minimise later handicap.
